Welcome!

Premium Services
- My Services
- None
- Other Services
- Champion Funds
- Duke Street
- Global Gains
- Hidden Gems
- Income Investor
- Inside Value
- Million Dollar Portfolio
- Motley Fool Pro
- Pay Dirt
- Ready-Made Millionaire
- Rule Breakers
- Rule Your Retirement
- Stock Advisor
- *Get a Fool Credit Card

Help Join Now or

Updated: 7/2/2009 4:22 PM					Sponsored by:
	DOW	8280.74	-223.32	-2.63%
	S&P 500	896.42	-26.91	-2.91%
	NASD	1796.52	0.00	0.00%

$5.67 0.36 (+6.78%)

7/2/2009 4:00 PM

Orexigen Therapeutics, Inc. (OREX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Current Price	$5.67	Mkt Cap	$184.26M
Open	$0.00	P/E Ratio	5.91
Prev. Close	$5.31	Div. (Yield)	N/A (N/A)
Daily Range	$5.00 - $5.69	Volume	0
52-Wk Range	$1.55 - $12.28	Avg. Daily Vol.	0

OREX News and Articles

Orexigen licenses obesity drug-related patents Jun 11 at 3:17 PM – Associated Press
Arena shares fall as drug misses an FDA benchmark Mar 30 at 2:20 PM – Associated Press
Arena shares fall as drug misses FDA benchmark Mar 30 at 1:39 PM – Associated Press
UBS downgrades Arena Pharmaceuticals, shares slide Feb 18 at 1:16 PM – Associated Press
Orexigen shares fall on mixed view of study data Jan 9 at 6:06 PM – Associated Press
Orexigen obesity drug reduces weight in study Jan 8 at 5:24 PM – Associated Press
Arena shares fall on failed study, cash concerns Dec 10 at 11:26 AM – Associated Press
Sector Snap: Obesity drug developers Nov 20 at 12:03 PM – Associated Press

All stories about OREX

Caps

How do you think OREX will perform vs the S&P 500?

Add Stock to Watchlist

All Members

54 Outperform

28 Underperform

All-Star Members

23 Outperform

14 Underperform

Wall Street

7 Outperform

0 Underperform

Top OREX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

fiordwalker (21.90)
Submitted March 25, 2008

weight loss drug could be a blockbuster

0 Comments | Reply | Report this Post

albanyfx (52.42)
Submitted February 29, 2008

OREX management panicked and accepted any horrible deal to get their hands on some cash. But there are a whole host of medical, technology, finance, manufacturing and retail names out there that are starving for capital. And you better believe that… More

0 Comments | Reply | Report this Post

OREX VS S&P 500 (SPY)

OREX Summary

Sector: Healthcare
Industry: Biotechnology
Tags: IPO in 2007 (232), Micro Cap (4683), Healthcare (770), Biotechnology (240)

Fools bullish on OREX are also bullish on:

Fools bearish on OREX are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about OREX.

Recs

LimoDriver1971 (97.18) Submitted: 7/1/2009 9:53:34 AM : Outperform

Start Price: $5.27 OREX Score: +10.59

My swecond pick related to the trend in this nation focusing on obesity.

As these new television shows start to portray overweight people in a more positive (help-able) light, this segment of doctors will come to the limelight, and will need the drugs and hardware to perform the operations and the maintenance that these people need.

Report this Post 0 Comments | Reply | Permalink

Recs

quinpeung (49.53) Submitted: 6/3/2009 3:21:12 PM : Underperform

Start Price: $4.38 OREX Score: -35.01

Surprised that OREX rose back over the threshold. This stock will likely bounce up and down for the next few months as management hypes their marginal obesity candidate.

Report this Post 0 Comments | Reply | Permalink

Recs

zzlangerhans (99.57) Submitted: 6/2/2009 11:53:01 PM : Underperform

Start Price: $4.19 OREX Score: -40.82

I'm suspicious of strong upward moves in Orexigen given the weakness of the completed phase III trial of Contrave. The company has an opportunity to redeem itself in Q3 with additional phase III Contrave data as well as phase II data for Empatic, but I don't see current highs being sustained through that point.

Report this Post 0 Comments | Reply | Permalink

View All 10 Pitches »

Leaderboard

Find the members with the highest scoring picks in OREX.

Score Leader

bigsmitty52 (98.68) Score: +94.49

You can't go wrong betting on Americans getting fatter.

Member Name	Member Rating	Start Date	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Commentary
bigsmitty52	98.68	3/20/2009	1Y	$2.69	+110.78%	+16.29%	+94.49	1 Comment
pdt24	< 20	3/30/2009	5Y	$2.80	+102.50%	+13.24%	+89.26
manetheren86	96.99	5/18/2009	5Y	$3.03	+87.13%	-0.65%	+87.78
gerbs87	86.21	5/12/2009	NS	$3.09	+83.50%	-1.99%	+85.48
Renton405	61.79	5/12/2009	5Y	$3.09	+83.50%	-1.99%	+85.48
cschier	62.10	5/15/2009	5Y	$3.09	+83.50%	+0.49%	+83.00
portefeuille	99.98	5/27/2009	3Y	$3.14	+80.57%	-1.78%	+82.36
Gemini846	91.80	5/27/2009	NS	$3.14	+80.57%	-1.78%	+82.36
CRAZYCAPTAIN	99.30	5/4/2009	1Y	$3.10	+82.90%	+1.42%	+81.48
ProCreditXpress	77.56	5/26/2009	NS	$3.10	+82.90%	+1.64%	+81.26

View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name	Member Rating	Start Date	Time Frame	Start Price	Stock Gain	S&P Gain	Score
TrackRodmanRen	81.15	6/24/2009	NS	$4.73	+19.88%	-1.19%	+21.06
TrackLeerinkSwan	93.59	8/25/2008	NS	$11.51	-50.74%	-30.27%	-20.47
TrackCowenandCo	78.61	4/3/2008	NS	$10.56	-46.31%	-33.96%	-12.34
TrackLazardCapit	41.24	2/6/2008	NS	$11.67	-51.41%	-33.22%	-18.20
TrackCanaccord	87.33	2/4/2008	NS	$11.59	-51.08%	-35.24%	-15.84
TrackJPMorgan	82.92	6/7/2007	NS	$17.76	-68.07%	-40.74%	-27.33
TrackJMP	29.30	6/6/2007	NS	$18.35	-69.10%	-41.27%	-27.83

Orexigen Therapeutics, Inc. (OREX)

OREX News and Articles

Caps